Proteomics Pathway Diagnostic Helps Identify Platinum-Refractory Ovarian Cancers
August 9, 2023 9:00 amA new study describes a new diagnostic approach that could help identify the 15% of women with ovarian cancer whose tumors are intrinsically refractory to standard platinum-based therapies, the most common type of chemotherapy for the disease.
Most ovarian cancers … Read more